Delivery Order SPE2DB24D1007-SPE2DB25FCCNG
- Not listed
- The Defense Logistics Agency awarded a $28,277.48 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on October 16, 2025, with an ultimate completion date of October 17, 2025. This contract utilizes a firm fixed-price structure and was competitively awarded without set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $15,468.22 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,808.28 for TREMFYA 100 mg/ml syringes on October 14, 2025, with completion scheduled for October 15, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $42,826.81 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Conshohocken, Pennsylvania location. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $11,751.35 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TREMFYA 100 mg/ml (one-press ml unit). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $42,749.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of TREMFYA 100 mg/ml injectable medication. The order, which represents a child contract under a larger indefinite delivery vehicle, was competitively awarded without set-aside provisions and carries an ultimate completion date of August 13, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $19,228.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of TREMFYA 100 mg/ml syringes. This is a non-set-aside, competitively awarded contract with performance to be completed by May 21, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $14,539.40 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive procurement of a specialized pharmaceutical product. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of TREMFYA 100 mg/mL in pen format, with a contract ceiling value of $30,669.82. This is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCNGDelivery Order
The Defense Logistics Agency awarded a $44,134.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TREMFYA 100 MG/ML syringes. The contract, which is scheduled for completion by July 21, 2025, represents a competitively awarded purchase with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a primary pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs and other federal medical systems. TREMFYA, a specialty pharmaceutical product, aligns with AmerisourceBergen's established portfolio of specialty medications and demonstrates the company's role as a critical vendor supporting Defense Health Agency and broader military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.1k | 7/18/25 |